UniDoc Appoints Industry Leader Eric Bacon as Telehealth Advisor
UniDoc Appoints Industry Leader Eric Bacon as Telehealth Advisor
This news release is not for distribution to U.S. newswire services for dissemination in the United States
Vancouver, BC – February 16, 2022 – UniDoc Health Corp. (“UniDoc Health” or the “Company”) (CSE: UDOC – ISIN: CA90468F1027 – WKN: A3C87U), an innovator in the telehealth sector, is pleased to announce that Mr. Eric Bacon, President of AMD Global Telemedicine Inc. has agreed to become the most recent advisory board appointee and will serve effective immediately.
Mr. Eric Bacon has spent the better part of the past two decades directing the design and integration of new telemedicine devices and telehealth technology solutions that have been deployed in over 100 countries and used in millions of consults. Through his efforts he has provided a vital role in the digital transformation of the healthcare industry and through his extensive international experience, he has participated in the design and deployment of some of the world’s largest telemedicine programs.
This involvement has provided Eric with a unique perspective of the challenges telemedicine programs face including geographical limitations, connectivity, clinical regulations, and reimbursement policies. He further brings an extensive background in financial reporting, international manufacturing, and regulatory affairs.
Preceding his current role as President, Eric served as Vice President of Finance and Operations at AMD. Previously, Eric worked in finance for a software engineering company and as a public accountant with KPMG in Boston. He currently serves as a member of a Healthcare Advisory Group for one of the world's largest technology companies and is a member of many trade and industry associations. He regularly presents at numerous telemedicine and healthcare IT forums throughout the world.
UniDoc CEO Antonio Baldassarre notes, “We are excited to have the chance to work with Mr. Bacon on an ongoing basis. We expect Eric’s generous participation as an advisor to our board will prove instrumental towards aligning our strategic planning and execution. His deep understanding of the sector is an opportunity to leverage his years of experience and unique industry perspective. On behalf of the team, our board and shareholders, we welcome him onboard and look forward to a great future together.”
On Behalf of The Board of Directors,
Sincerely,
Antonio Baldassarre
CEO, President & Director
UniDoc Health Corp. (CSE: UDOC)
As part of the Company’s disclosure obligations as a public issuer, ongoing financial and material filings can be found under the Company’s profile on the System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com.
About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T)
UniDoc is developing a telehealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician’s office. Telehealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company’s belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch, and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events, and progress. You are also invited to join us on social media with Facebook, Twitter or Instagram.
For further information, please contact:
UniDoc Investor Relations
Tel: +1 778.383.6731
Email: info@unidoctor.com
Austin Thornberry, Director
Tel: +1 647.463.8689
Email: austin@unidoctor.com
Media Inquiries
About this press release:
In Germany this press release is brought to you by www.aktien.news – your German news platform for international smallcap stocks. For more information visit https://www.akt.ie/nnews.
Forward-Looking Statement
This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as “may”, “would”, “could”, “will”, “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the anticipated results of Mr. Bacon’s role on the Company’s advisory board.
Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company’s ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks as described in the Company’s final prospectus dated December 2, 2021 under the heading “Risks Factors.” Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.
The CSE does not accept responsibility for the adequacy or accuracy of this release.